Evaluation of contrast-enhanced harmonic endoscopic ultrasonography guided fine needle aspiration(EUS-FNA)of pancreatic tumor: a prospective single center study.

Evaluation of contrast-enhanced harmonic endoscopic ultrasonography guided fine needle aspiration(EUS-FNA)of pancreatic tumor: a prospective single center study. - Evaluation of contrast-enhanced harmonic endoscopic ultrasonography guided fine needle aspiration(EUS-FNA)of pancreatic tumor

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000024467

Enrollment

Registered

2016-10-19

Start date

2016-10-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

pancreatic tumor

Interventions

contrast-enhanced harmonic EUS-FNA

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: # pancreatic tumor cases with pancreatic mass requiring EUS-FNA # Written informed consent

Exclusion criteria

Exclusion criteria: # inability to perform endoscopy # Performance status=4 # Failure of other organs # inability to obtain informed consent # allergy of contrast agent

Design outcomes

Primary

Measure	Time frame
accuracy	—

Secondary

Measure	Time frame
appropriate sampling rate	—

Countries

Japan

Contacts

Public ContactMasahiro Itonaga

Wakayama Medical University Second Department of Internal Medicine

itonaga@wakayama-med.ac.jp073-447-2300

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026